Covance Rings Closing Bell at NYSE

Friday, January 12, 2007 04:51 PM

Chairman and chief executive officer Joe Herring of the Princeton, New Jersey-based CRO Covance ran the closing bell at the New York Stock Exchange (NYSE) on Thursday. The event was to honor Covance's tenth year as a publicly traded company. On the company 1st day of opening trading in 1997, Covance's stock was worth $19.25 per share. Ten years later, the stock is worth more than $60 per share; closing Friday at $63.36.

The company has annual revenues of more than $1.3 billion, operates in 18 countries and employs over 7,000 employees. The company was born in 1997 after being spun off, along with the global laboratory services giant Quest Diagnostics, from Corning Inc.

A video of the event can be seen on the NYSE opening bell schedule website. Or watch it here.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs